2016 International Congress Archives - Page 53 of 207

ICF-based effects of VIM-DBS on communication in everyday life in patients with essential tremor

M. Hartinger, M. Scholz, D. Mücke, A. Hermes, T.B. Roettger, J. Becker, M. Opitz, T.A. Dembek, I.G. Meister, V. Visser-Vandewalle, M. Grice, L. Timmermann, M.T. Barbe (Berlin, Germany)
Identification of a new biomarker in a mouse model of essential tremor using EEG

V. Duveau, B. Mandé, B. Pouyatos, Y. Roche, C. Roucard (La Tronche, France)
Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers

C.S. Hurt, L. Rixon, K.R. Chaudhuri, R. Moss-Morris, M. Samuel, R.G. Brown (London, United Kingdom)
Identification of premotor Parkinson’s disease

K.C. Hughes, X. Gao, M.A. Schwarzschild, A. Ascherio (Boston, MA, USA)
Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS

V. Vedam-Mai, S. Sternberg, M. Williams, T. Garrett, M.S. Okun (Gainesville, FL, USA)
Identification of Usp8 as a toxicity modifying deubiquitinase for α-synuclein

Z. Alexopoulou, J. Lang, R. Perrett, H.T. Kim, A.L. Goldberg, O. Ansorge, T.A. Fulga, G.K. Tofaris (Oxford, United Kingdom)
Identifying freezing of gait and falls in Parkinson’s disease patients using a body-worn sensor

Y. Okuma, H. Mitoma, M. Yoneyama (Izunokuni, Japan)
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review

C.M.K.E. de Cuba, A. Albanese, A. Antonini, G. Cossu, G. Deuschl, R. Eleopra, A. Galati, C.F.E. Hoffman, K. Knudsen, A. Landi, M.M.R. Lanotte, A. Marcante, A. Mosch, M. Pilleri, M.M. Reich, V. Ricchi, S. Rinaldo, L.M. Romito, F. Saba, H.E. Sacristan, P.R. Schuurman, A. Trezza, P. van den Munckhof, J. Volkmann, M. Zibetti, M.F. Contarino (Amsterdam, Netherlands)
Idiopathic Parkinson’s disease presenting with dysphagia 15 years before PD diagnosis

T. Munteanu, C. Goggins, D. Costigan, J. Molloy, T. O'Dwyer, T. Lynch (Dublin, Ireland)
IL-6 and motor symptoms in Parkinson’s disease

T. Torgan, T. Baidina, N. Demchuk, M. Danilova (Perm, Russia)
Illusional perception in Parkinson’s disease

C. Ding, C. Palmer, J. Hohwy, G. Youssef, B. Paton, N. Tsuchiya, J. Stout, D. Thyagarajan (Clayton, Australia)
Imaging correlates of hypodipsia in progressive supranuclear palsy

G. Respondek, T. Conrad, I. Riederer, T. Reeß, G. Rus, K. Koch, G. Höglinger, C. Zimmer (Munich, Germany)
Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease

W. Sako, T. Abe, N. Murakami, Y. Miyazaki, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)
Imitation of hand movements in Parkinson’s disease: A comparison with visual cueing

J. Bek, E. Gowen, S. Vogt, T. Crawford, E. Stack, J. Dick, E. Poliakoff (Manchester, United Kingdom)
Impact of a holistic and interdisciplinary care for patients with Parkinson’s disease – Cologne Parkinson’s network. Results of a randomized study with subanalysis

R.A. Dano, J. Schill, L. Rochhausen, K. Williamson, L. Timmermann, C. Eggers (Cologne, Germany)
Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease

E. De Pablo-Fernandez, C. Tur, T. Revesz, J.L. Holton, T.T. Warner (London, United Kingdom)
Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)
Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population

G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge-de Sarachaga, D. Cruz-Fino, J. Pascacio-Astudillo, R. Llorens-Arenas (Mexico City, Mexico)
Impact of chronic LD treatment on metabolism, blood flow and blood-brain barrier permeability in the 6-OHDA rat model

R.P. Lerner, Z. Bimpisidis, V. Jourdain, T. Chaly, M. Hellman, K. Graf, V. Dhawan, S. Dewey, A. Cenci, D. Eidelberg (Manhasset, NY, USA)
Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease

A.V. Shalaeva, N.A. Dadabaeva, R.M. Allanov, M.B. Bozorboev, E. Shalaeva (Tashkent, Uzbekistan)
Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)
Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients

T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)
Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson’s disease

C. Francois, I. Biaggioni, C.A. Shibao, A. Ogbonnaya, H.C. Shih, E. Farrelly, A. Ziemann, A. Duhig (Deerfield, IL, USA)
Impact of pre- and postdiagnosis physical activity on the progression of Parkinson’s disease

I.F. Shih, K.C. Paul, Y. Bordelon, J.M. Bronstein, B. Ritz (Los Angeles, CA, USA)
Impact of prolonged temporal discrimination threshold on finger movements of Parkinson’s disease

M.J. Lee, J.S. Son, J.H. Lee, S.J. Kim, C.H. Lyoo, M.S. Lee (Busan, Korea)
Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients

D. Cook, C. McRae, R. Kumar (Englewood, CO, USA)
Impact of sociodemographic and clinical characteristics on cognition of individuals with Parkinson’s disease

M.R. Olchik, A. Ayres, M. Ghisi, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)
Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease

M.A. Higuchi, T. Mishima, H. Abe, T. Morishita, S. Fujioka, J. Fukae, Y. Tsuboi (Fukuoka, Japan)
Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus

A. Benazzouz, C. Delaville, E. Faggiani (Bordeaux, France)
Impact of white matter hyperintensity on motor compensation in Parkinson’s disease

J.J. Lee, Y. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Korea)
Impaired cerebellum to motor cortex associative plasticity in Parkinson’s disease

M.K. Lu, C.M. Chen, J.R. Duann, C.H. Tsai (Taichung, Taiwan)
Impaired color discrimination selectively associates with postural instability and gait difficulties in Parkinson’s disease

J.D. Haugen, M.L.T.M. Muller, N.I. Bohnen (Ann Arbor, MI, USA)
Impaired cube copy on the MOCA indicates worse performance in several cognitive domains in Parkinson´s disease

C. Gasca-Salas, M. Cohn, J.A. Pineda, J.A. Obeso (Madrid, Spain)
Impaired eye voice coordination in spinocerebellar degeneration while reading aloud

Y. Terao, S. Tokushige, S. Terada, T. Sasaki, M. Hamada, S. Tsuji, Y. Ugawa (Tokyo, Japan)
Impaired hippocampal neurogenesis associates with serotonergic axonal degeneration in transgenic rat and mouse models of Parkinson’s disease

Z. Kohl, J. Deußer, D. Amato, C.P. Müller, O. Riess, E. Masliah, S. Nuber, J. Winkler (Erlangen, Germany)
Impaired processing of visuo-spatial information in cervical dystonia patients

C.J. Amlang, C. Hubsch-Bonneaud, S. Rivaud-Pechoux, S. Mehdi, A. El Helou, Y. Trotter, J.B. Durand, P. Pouget, M. Vidailhet (Berlin, Germany)
Impaired response times to luminance stimuli in dystonia patients indicate disordered superior colliculus processing

L. Williams, J.S. Butler, B. Quinlivan, A. Molloy, E. McGovern, I. Beiser, M. Thirkettle, S. O'Riordan, P. Redgrave, R. Reilly, M. Hutchinson (Dublin, Ireland)
Impaired temporal coupling of action and perception in Parkinson’s disease

E. Pretegiani, N. Vanegas-Arroyave, E. FitzGibbon, M. Hallett, L.M. Optican (Bethesda, MD, USA)
Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game

A.C. Parr, B.C. Coe, G. Pari, D.P. Munoz (Kingston, ON, Canada)
Impairments in trunk muscle function influence head and trunk stability during walking in Parkinson’s disease fallers

M.H. Cole, G.A. Naughton, P.A. Silburn (Virginia, Australia)
Implantable pulse generator (IPG) longevity decreases following each replacement surgery in Parkinson’s disease (PD) patients treated with bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS)

S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin (Ramat Gan, Israel)
Implementation of a mobile application in the Luxembourg Parkinson’s study for identification and validation of disease stage and variation

R. Krüger, G. Hipp, M. Kerschenmeyer, P.L. Kolber, A. Trister, C. Suver, V.P. Satagopam, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Balling, S. Friend (Belvaux, Luxembourg)
Implications of direct and indirect costs in health-related quality of life in Parkinson’s disease: A cross-sectional study in Mexico

M. Rodríguez-Violante, A. Jorge de Saráchaga, A. Cervantes-Arriaga, H. Soto-Molina, M. Márquez-Cruz (Mexico City, Mexico)
Improved motor functioning of people with Parkinson’s disease following dance intervention

S.M. Simone, K.A. Beben, S.E. Maguire, C. Noudga, K.L.M. Martin, G.N. Luabeya, P. Dhami, R.J. Bar, J.F. DeSouza (Toronto, ON, Canada)
Improvement in posture, pain, and cardiac autonomic function in a prospective study of osteopathic manipulative medicine and physical therapy for camptocormia in Parkinson’s disease

J.D. Mancini, D.M. Pasternack, N. Caruana, A. Leder (Old Westbury, NY, USA)
Improvement of foot progression in cervical dystonia using osteopathic manipulative medicine

J.D. Mancini, Z. Oliff, A. LaRosa, S. Mody, R. Abu-Sbaih, A. Leder (Old Westbury, NY, USA)
Improvement of freezing of gait with intestinal levodopa infusion in advanced Parkinson’s disease patients

M. Zibetti, S. Angrisano, F. Dematteis, A. Romagnolo, A. Merola, L. Lopiano (Torino, Italy)
Improvement of impulse control disorder in Parkinson’s disease patients treated with subthalamic nucleus stimulation

E.J. Choi, J.K. Gu, D.G. Lee, S.M. Kim, J.K. Lee, C.S. Lee (Seoul, Korea)
Improvement of levodopa induced foot dystonia with 60 Hz frequency subthalamic- deep brain stimulation

J.P. Battista, R.A. Ramdhani (New York, NY, USA)
Improvement of post-stroke fixed dystonia of upper and lower limb following DBS of internal capsule: Report of two cases

G. Messina, V. Levi, R. Cordella, I. Dones, A. Franzini (Milan, Italy)
Improvement of saccade amplitude by the STN DBS and visual target eccentricity

A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)
Improving clinical detection of balance deficits in individuals with Parkinson’s disease with and without freezing of gait and the effects of dopaminergic replacement therapy

K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)
Improving drug discovery using brain oscillations as biomarkers of Parkinson’s disease

B. Pouyatos, S.J. Perry, D.E. Grigoriadis, R. Maury, C. Bouyssières, C. Roucard, V. Duveau, Y. Roche (La Tronche, France)
Improving parkinsonism in DBS poor-responders by surgical lead revision of subthalamic electrodes

R.C. Nickl, M.M. Reich, S. Johannes, F. Steigerwald, P. Fricke, V. Sturm, R.I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)
Improving provision of Parkinson’s disease exercise classes

C. Carroll, P. Pujara, J. Rideout (Plymouth, United Kingdom)
Improving the experience of diagnosis in Parkinson’s disease

C. Carroll, B. Blight, V. Evans, N. Hawkes, J. Davis (Plymouth, United Kingdom)
Impulse control disorder associates with tyrosine hydroxylase 2 gene variants in Parkinson’s disease patients subject to dopaminergic therapy

I. Legarda, B. Vives, C.A. Beltran-Gomila, B. Ortega-Vila, M. Ruiz, J. Pol-Fuster, C. Vives-Bauza (Palma, Spain)
Impulse control disorder in early Parkinson’s disease: Follow-up study

V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, M. Jecmenica-Lukic, A. Tomic, V. Kostic (Belgrade, Serbia)
Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance

J. Marin-Lahoz, R. Fernandez-Bobadilla, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Perez-Perez, H. Bejr-Kasem, A. Gironell, J. Kulisevsky (Barcelona, Spain)
Impulse control disorders after STN DBS for Parkinson’s disease

P.G. Frederic, P. Camille, J. Nicolas, S. Abbas, F. Maria, P. Michel (Montreal, QC, Canada)
Impulse control disorders in Parkinson’s disease – Determinants and effect of DBS

A.K. Puligopu, P.K. Pesala, V.V.P. Kagita, R.M. Kandadai, S.A. Jabeen, M.A. Kanikannan, R. Borgohain, A. Kumar (Hyderabad, India)
Impulsive action tendencies in GPi DBS Parkinson’s patients

D. Martinez-Ramirez, C.S. Little, J.P. Chapman, S. Carbunaru, J.C. Giugni, M.W. Vasquez, F. Chai, R. Walz, A. Sririam, K. Kanoff, S.A. Wylie, M.S. Okun (Gainesville, FL, USA)
Impulsive-compulsive behaviors in patients with Parkinson’s disease and demographically-comparable group of healthy controls

M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya, S.E. Sukhanov (Tomsk, Russia)
In idiopathic Parkinson’s disease: The effect of using L-dopa on peripheral nerves

M.E. Temir, F. Genç, Y. Biçer Gömceli, A. Yaman, A. Aybar, E. Karaçay (Antalya, Turkey)
In utero delivery of scAAV9 mediates widespread brain transduction in rats and monkeys: Towards new models of Parkinson’s disease

M. Bourdenx, L. Chansel-Debordeaux, S. Dovero, V. Grouyhier, N. Dutheil, S. Brun, A. Espagna, L. Groc, Q. Li, C. Jimenez, E. Bezard, B. Dehay (Bordeaux, France)
In vivo MRI detection of Parkinson’s disease associated degeneration in the lateral ventral tier of substantia nigra pars compacta

D.E. Huddleston, J. Langley, J. Sedlacik, K. Boelmans, S.A. Factor, X. Hu (Atlanta, GA, USA)
In vivo validation of a new wireless portable stimulator for chronic deep brain stimulation in freely moving rats

F. Naudet, F. Kölbl, G. N'kaoua, E. Faggiani, B. Ribot, S. Renaud, N. Lewis, A. Benazzouz (Bordeaux, France)
In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia

J.C. DeSimone, M. Febo, P. Shukla, E. Ofori, L.M. Colon-Perez, Y. Li, D.E. Vaillancourt (Gainesville, FL, USA)
Incidence and characteristics of gait dysfunction after subthalamic nucleus deep brain stimulation

V. Velez-Aldahondo, A.B. Millard, J.R. Jagid, C.C. Luca (Miami, FL, USA)
Incidence and etiologies of pediatric asterixis

B.R. Aravamuthan, J.L. Waugh (Boston, MA, USA)
Incidence of dynamic aphasia in progressive supranuclear palsy

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)
Incidence of dystonia in patients with progressive supranuclear palsy

E.I. Giyazitdinova, B.T. Muinjonov, G.S. Rakhimbaeva, Y.A. Musaeva (Taskent, Uzbekistan)
Incidence of fragility fractures in people with parkinsonism [PwP] – A 5 year retrospective observational study

S. Aithal, C. Thomas, S. Raha, H. Shukla, L. Ebenezer, R. Sequeria, B. Mohamed (Caerphilly, United Kingdom)
Incidence of waning tremor control in essential tremor patients with deep brain stimulation

M.D. Seier, A. Hiller, C. Murchison (Portland, OR, USA)
Incidental finding of drug-induced movement disorder

G. Avagyan, H. Manvelyan, A. Nazaryan (Yerevan, Armenia)
Increase L-dopa dosage for rest tremor or think about the essential tremor too?

A. Voskanyan, G. Avagyan, E. Khachatryan, K. Harutyunyan, S. Khachaturyan, H. Amirjanyan, H. Manvelyan (Yerevan, Armenia)
Increased access to training in a Parkinson-specific rehabilitation approach through online learning

C. Fox, L. Guse, L. Ramig (Tucson, AZ, USA)
Increased anti-MAG autoantibodies titers in Parkinson’s disease

E. Papuc, K. Rejdak (Lublin, Poland)
Increased cellular co-localization of tau fragment 1-368 and alpha-synuclein in two mouse model of Parkinson’s disease

K. Ma, S. Nie, G. Chen, C. Han, X. Guo, Y. Xu, X. Cao (Wuhan, People's Republic of China)
Increased cerebrospinal fluid lactate levels in Parkison’s disease: Is it a proof of mitochondrial inefficiency?

C. Liguori, A. Stefani, E. Olivola, N.B. Mercuri, M. Pierantozzi (Rome, Italy)
Increased cortical control of gait in patients with Parkinson’s disease and freezing of gait

G.J. Revuelta, C. Chan, S. Jenkins, J. Jensen, L. Bonilha (Charleston, SC, USA)
Increased energy expenditure in early Parkinson’s disease during exercise

T. Margaliot Kalifa, N. Ziv, H. Bergman, S. Nusair, D. Arkadir (Jerusalem, Israel)
Increased monosaccharide intake in patients with Parkinson’s disease

E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)
Increasing placebo response in Parkinson’s disease through apomorphine pre-conditioning

E. Frisaldi, E. Carlino, L. Giudetti, A. Pampallona, M. Zibetti, M. Lanotte, L. Lopiano, F. Benedetti (Turin, Italy)
Independent validation of the quality of life in essential tremor questionnaire (QUEST)

N. Kovács, A. Makkos, M. Kovács, J. Janzsky (Pécs, Hungary)
Indirect comparison of tolerability of deutetrabenazine and tetrabenazine in the FIRST-HD and TETRA-HD trials

D.O. Claassen, B. Carroll, L.M. De Boer, E. Wu, R. Ayyagari, S. Gandhi, D. Stamler (Nashville, TN, USA)
Individualized botulinum toxin type A therapy of bilateral upper limb essential tremor by multi-sensor kinematic technology

O. Samotus, H. Moradi, M. Jog (London, ON, Canada)
Induced pluripotent stem cell-derived cortical neurons as a disease model for X-linked dystonia-parkinsonism

K. Grütz, C. Krause, A. Domingo, L. V Lee, R. Rosales, R.D. Jamora, E. Cutiongco dela Paz, A. Westenberger, C. Klein, P. Seibler (Lübeck, Germany)
Inferring the causal interplay of motor related brain areas in the aging brain: A dynamic causal modeling (DCM) approach

F. Jung, P. Löhrer, F. Nettersheim, I. Weber, T.A. Dembek, C. Huber, E.A. Pelzer, M. Tittgemeyer, L. Timmermann (Cologne (Köln), Germany)
Inferring the coupling of motor related brain areas during paced finger tapping in Parkinson’s patients

V. Seeger, F. Jung, L. Schneider, T.A. Dembek, P. Reker, N. Apetz, M. Tittgemeyer, L. Timmermann (Cologne, Germany)
Inflammatory profile discriminates clinical subtypes in LRRK2-associated PD

K. Brockmann, C. Schulte, N. Schneiderhan-Marra, A. Apel, C. Pont-Sunyer, D. Vilas, J. Ruiz-Martinez, M. Langkamp, J.C. Corvol, F. Cormier, T. Knorpp, T.O. Joos, A. Bernhard, T. Gasser, C. Marras, B. Schüle, J.O. Aasly, T. Foroud, J.F. Marti-Masso, A. Brice, E. Tolosa, D. Berg, W. Maetzler (Tübingen, Germany)
Influence of different spike sorting algorithms on the detection of single unit spiking activity in the subthalamic nucleus of patients with Parkinson’s disease

J. Sukiban, R. Pauli, T.A. Dembek, I. Weber, F. Jung, N. Voges, M. Denker, S. Gruen, L. Timmermann (Cologne, Germany)
Influence of high altitude on periodic leg movements during sleep in individuals with restless legs syndrome and healthy controls: A pilot study

A. Stefani, A. Heidbreder, H. Hackner, M. Burtscher, B. Högl (Innsbruck, Austria)
Influence of lateral wedges on postural control in patient with Parkinson’s disease

J. Park, J. Yoon, W. Jang, J.S. Kim, J. Youn, E.S. Oh (Busan, Korea)
Influence of levodopa on functional brain connectivity in Parkinson’s disease

S. Kobayashi, K. Asano, N. Matsuda, H. Kubo, M. Abe, Y. Ugawa (Fukushima-shi, Japan)
Influence of motor manifestation and onset’s side on the spectrum of non-motor symptoms in patients with Parkinson’s disease

M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya (Tomsk, Russia)
Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)
Influence of treadmill gait training with additional load on motor function, postural instability and history of falls for individuals with Parkinson’s disease: A randomized clinical trial

L.C.L. Trigueiro, A.V.C. Sousa, G.L. Gama, T.S. Ribeiro, L.G.L.M. Ferreira, C.R. Simão, É.R.V.P. Galvão, E.M.G.S. Silva, C.G. Júnior, A.R.R. Lindquist (Natal, Brazil)
Influence of vibration to quality of life of patients with Parkinson’s disease

V. Rashidov (Tashkent, Uzbekistan)
Inhibition of cathepsin D enhances the autophagy lysosome pathway dysfunction and α-synuclein aggregation in experimental parkinsonism

L. Li, Y.P. Yang, L. Gao, Y. Song, Z. Liang (Suzhou, People's Republic of China)
Inhibition of glucosylceramide synthase reduces pathology and improves cognition in synucleinopathy murine models

L. Shihabuddin, C. Viel, J. Clarke, H. Park, J.C. Dodge, J. Marshall, B. Wang, S.H. Cheng, S.P. Sardi (Framingham, MA, USA)
Inhibition of nociceptive responses by modulating serotonergic signals at the rostral ventromedial medulla in 6-OHDA-induced Parkinson’s disease rat model

C. Wang, C. Mao, F. Wang, J. Yang, X. Zhang, Y. Yang, C. Liu (Suzhou, People's Republic of China)
Inhibition of the mitochondrial calcium uniporter (MCU) rescues dopaminergic neurons in pink1-/- zebrafish

B. Oliver, S. Solman, M. Keatinge, M. DaCosta, H. Mortiboys, S. Sugunan, J. Kuznicki (Sheffield, United Kingdom)
Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)
Innsbruck multiple system atrophy cohort study – An interim analysis

S. Eschlböck, T. Benke, S. Bösch, A. Djamshidian-Tehrani1, A. Fanciulli, R. Granata, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)
Instrumented quantitative study of movement and gait in Parkinson’s disease clinical subtypes

P.C. Gordon, J.B. Ferraz, L.M. Medeiros, L.F.R. Oliveira, D.K. Amado, A.M. Lima Neto, M.S.G. Rocha (Sao Paulo, Brazil)
Insulin dependent diabetes and hand tremor

S. Khachaturyan, G. Avagyan, K. Harutyunyan, A. Voskanyan, I. Gabrielyan, H. Amirjanyan, H. Manvelyan (Echmiadzin, Armenia)
Integrity of the superior longitudinal fascicle and its relationship with anticipatory postural adjustments in people with Parkinson’s disease and freezing of gait

A.C. de Lima-Pardini, T.Q. Freitas, D.B. Coelho, C.C. Boffino, C. Souza, R. Brandt, E.R. Barbosa, L.A. Teixeira, E. Amaro Jr. (São Paulo, Brazil)
Interdisciplinary allied health care in a southern Brazil service

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)
Interest in genetic testing in Parkinson’s disease patients with deep brain stimulation

G. Pal, E. Tam, R. Bhavsar, C. Timms, L. Verhagen, D. Hall, K. Marder (Chicago, IL, USA)
Interleaved pro- and anti-saccade performance in Huntington’s disease

I. Vaca-Palomares, J. Fernandez-Ruiz, B. Coe, D.P. Munoz (Kingston, ON, Canada)
International differences in the baseline characteristics and clinical management of cervical dystonia patients presenting for botulinum toxin treatment in routine practice

D. Charles, T.M. Chung, V.P. Misra, C. Colosimo, S. Om, P. Maisonobe (Nashville, TN, USA)
Interrelation between gait impairment with cognitive disturbances in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)
Intracerebroventricular D-galactose injection provokes motor coordination impairment and cerebellar damage in Wistar rats

A.F. Rodrigues, B.S. Zanotto, H. Biasibetti, P. Pierozan, F. Schmitz, E.F. Sanches, D. Delwing Dal Magro, C.A. Netto, A.T.S. Wyse (Brusque, Brazil)
Intracranial calcifications in children and adults: Molecular and phenotypic characterization from a tertiary referral centre

C. Panteghini, M. Carecchio, D. Tonduti, C. Barzaghi, L. Magistrelli, A. Decio, L. Chiapparini, A. Pichiecchio, S. Esposito, C. Pantaleoni, D. Riva, I. Moroni, S. Orcesi, N. Nardocci, B. Garavaglia, Cerebral Calcification Study Group (Milan, Italy)
Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)
Intrastriatal injection of ionomycin profoundly changes motor response to L-DOPA and its underlying molecular mechanisms

C. Han, S. Nie, G. Chen, K. Ma, N. Xiong, Z. Zhang, Y. Xu, T. Wang, S.M. Papa, X. Cao (Wuhan, People's Republic of China)
Introducing the 2nd edition of the occupational therapy for people with Parkinson’s: Best practice guidance

A. Aragon (Bath, United Kingdom)
Investigating the plastic effects of rapid paired associative stimulation in dystonia

V.F.M. Ramos, P. Srivanitchapoom, S. Pandey, A. Holmes, S. Kukke, R. Paine, N. Thirugnanasanbandam, N. Dang, M. Hallett (Bethesda, MD, USA)
Investigating the relationship between reaction time and cognition in Parkinson’s disease

J. Cosgrove, C. Picardi, S.L. Smith, S. Jamieson, J.E. Alty (Leeds, United Kingdom)
Investigating the role of Parkin in mitigating oxidative stress

J.M. Tokarew, D. El Kodsi, J.T. Tomlinson, M.G. Schlossmacher (Ottawa, ON, Canada)
Investigating voice as a biomarker of LRRK2-associated Parkinson’s disease (PD)

S. Arora, N.P. Visanji, T.A. Mestre, T. Ghate, A.E. Lang, M. Little, C. Marras (Birmingham, United Kingdom)
Investigation into the genetic etiology in South African Parkinson’s disease patients

G. Borrageiro, L. Van den Heuvel, S.M.J. Hemmings, S. Seedat, S. Bardien (Cape Town, South Africa)
Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview

R. Ando, C. Yamazaki, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, K. Nakashima, M. Nomoto, Safe Driving Study Group of Japan (Tohon, Japan)
Investigation of head tremor in cervical dystonia: Novel application of virtual reality head mounted display, the oculus rift

I.M. Beiser, B. Quinlivan, E. McGovern, L.J. Williams, S. Narasimham, O. Killian, R. Beck, G. Colvert, S. O'Riordan, J.S. Butler, R.B. Reilly, M. Hutchinson (Dublin, Ireland)
Investigation of mosaicism for copy number variants in PD brain

C. Proukakis, K. Mokretar, A. Ejaz, A. Soenmez, C. Grace, D. Pease, H. Houlden, J.W. Taanman, A.H. Schapira, E. Nacheva (London, United Kingdom)
Investigation of the influence of the parieto-premotor network on the motor cortex in writer’s cramp using transcranial magnetic stimulation

J.E. Park, P. Mathew, M. Villegas, P. Srivanitchapoom, M. Hallett (Bethesda, MD, USA)
Involvement of cerebellothalamocortical pathway in essential tremor and dystonic tremor

P. Panyakaew, H.J. Cho, P. Srivanitchapoom, M. Hallett (Bethesda, MD, USA)
Involvement of peripheral immune system in the pathogenesis of Parkinson’s disease

Y.X. Chao, S.C. Wong, K.J. Puan, J.J.Y. Tai, O. Rötzschke, B. Lee, M. Poidinger, E.K. Tan (Singapore, Singapore)
iPad-based preassessment questionnaires are feasible in a Parkinson’s service

B. Mohamed, E.L. Lane, E.C. Thomas, M. Landwehr, C.W. Ngu, J. Butler, K. Williams, M. Wardle (Cardiff, United Kingdom)
Iron accumulation and volume loss in the extrapyramidal motor system in Friedreich ataxia: The IMAGE-FRDA study

I. Harding, M. Delatycki, L. Corben, P. Raniga, M. Stagnitti, E. Storey, N. Georgiou-Karistianis, G. Egan (Melbourne, Australia)
Iron accumulation in a Wilson disease patient: Longitudinal 7T MRI and transcranial sonography study

P. Dusek, D. Skoloudik, J. Maskova, T. Huelnhagen, R. Bruha, D. Zahorakova, T. Niendorf, E. Ruzicka, S.A. Schneider, J. Wuerfel (Prague, Czech Republic)
Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)
Is Apple Watch a new hope for patients with Parkinson’s disease?

H. Ohtsubo, H. Iwaki, R. Andou, T. Tsujii, H. Babe, N. Nishikawa, M. Nagai, M. Nomoto (Tohon, Japan)
Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)
Is continuous twenty four hour blood pressure monitoring a suitable tool in evaluating sleep disturbances in Parkinson’s disease?

M. Hahne, D. Hartmann, C. Thomopoulos, A. Ramih, M. Esther, Y. Guangji, G. Bernd, W. Dirk, R. Heinz, J. Wolfgang (Bad Neustadt, Germany)
Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)
Is it just a coincidence? Three new cases of Parkinson’s disease associated with myasthenia gravis

G. Sciacca, A. Nicoletti, E. Reggio, G. Mostile, M. Zappia (Catania, Italy)
Is levodopa-induced dyskinesia in Parkinson’s disease associated with increased blood brain barrier permeability and volumetric changes?

O. Segal, D. Last, D. Guez, Y. Mardor, G. Yahalom, O.S. Cohen, S. Benizri, C. Hoffman, S. Hassin-Baer (Ramat Gan, Israel)
Is physiotherapy an effective for treatment of Parkinson’s disease?!

R. Agzamov, S. Tursunov, G. Rakhimbaeva, F. Yunusov, D. Lutfullaeva, J. Olimov, A. Kalendarev, K. Abdukhalimova, R. Mirzaev (Tashkent, Uzbekistan)
Is the assessment of 5 meters of gait with body-worn-sensors enough to recognize Parkinsonian gait?

M.E. Micó Amigo, I. Kingma, A. Kunikoshi, R.V. Lummel, W. Maetzler, J.V. Dieën (Amsterdam, Netherlands)
Is the defective gait automaticity associated to deficiencies in implicit learning in patients with Parkinson’s disease?

M.E.P. Piemonte, A.F. Helene, B. Monte, E.N. Guelfi, E. Okamoto, C. Vargas, J.A. Galves (Sao Paulo, Brazil)
Is the PPN a valuable target for deep brain stimulation in treatment of Parkinsonian disorders? Experience of a patient’s series

I. Galazky, A. Kupsch, E. Wirkus, F. Casjens, S. Specht, H.J. Heinze, J. Voges (Magdeburg, Germany)
Is the selection of stepping impaired in PD in ON state?

C. Stummer, E. Mallia, J. Rothwell, B.R. Bloem, V. Weerdesteyn (Nijmegen, Netherlands)
Is there any relationship between olfactory dysfunction and memory disorder?

H. Onuma, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara-city, Japan)
Is tremor related to celiac disease?

L. Ameghino, M.D. Rossi, D. Cerquetti, M. Merello (Buenos Aires, Argentina)
Isolated eyebrow tremor as an initial presentation form of Parkinson´s disease

E. Lopez Valdes, M. Catalán, R. Garcia-Ramos, P. Montero, I. Parees, F. Alonso (Madrid, Spain)
Isolated finger tremor in Parkinson’s disease and essential tremor

F. Alonso-Frech, H. García-Moreno, P. Montero Escribano, E. López Valdés, M.J. Catalán Alonso, R. García-Ramos García, I. Parees Moreno (Madrid, Spain)
Isolated micrographia following stroke

P. Montero Escribano, M.J. Catalán Alonso, F. Alonso French, E. López Valdés, R. García Ramos, I. Parees Moreno (Madrid, Spain)
Italian olfactory identification test (IOIT) scores correlates with clinical features in Parkinson’s disease

E. Brahimi, N. Tambasco, P. Eusebi, P. Nigro, E. Sacchini, S. Simoni, E. Marsili, F. Ripandelli, M. Romoli, P. Calabresi (Perugia, Italy)